Better to issue tokens

According to PANews, the U.S. publicly traded biopharmaceutical company Galmed Pharmaceuticals Ltd. has announced the implementation of a digital asset management strategy. The company plans to invest $10 million in digital assets, which represents 50% of its current cash reserves. A cryptocurrency committee has been established to assess and oversee cryptocurrency-related investment activities. This strategy includes portfolio rebalancing of digital assets, participation in liquidity provision, staking yield, and risk hedging strategies. Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona, which will provide consulting and operational services.